Why Allarity Therapeutics (ALLR) Stock Is Getting Hammered
Why Allarity Therapeutics (ALLR) Stock Is Getting Hammered
Allarity Therapeutics Inc (NASDAQ:ALLR) shares are trading lower by 28.40% to $0.32 during Monday's session after the company announced it received a noncompliance letter from the Nasdaq.
Allarity Therapeutics Inc（納斯達克股票代碼：ALLR）在週一的交易中股價下跌28.40％，至0.32美元，此前該公司宣佈收到 違規信 來自納斯達克。
On June 18, Allarity received a notice from Nasdaq indicating the company failed to meet the requirement of maintaining a minimum bid price of $1 per share for 30 consecutive business days. Allarity plans to request a hearing to appeal for continued listing.
6月18日，Allarity收到納斯達克的通知，表明該公司未能滿足連續30個工作日維持每股1美元的最低出價的要求。Allarity計劃要求舉行聽證會，以上訴繼續上市。
This request will temporarily prevent the suspension and delisting of its stock until the hearing concludes. However, there is no guarantee that the appeal will be successful and that the company's stock will continue to be listed on the Nasdaq Capital Market.
在聽證會結束之前，該請求將暫時阻止其股票暫停和退市。但是，無法保證上訴會成功，也無法保證該公司的股票將繼續在納斯達克資本市場上市。
According to data from Benzinga Pro, ALLR has a 52-week high of $269.80 and a 52-week low of $0.32.
根據Benzinga Pro的數據，ALLR的52周高點爲269.80美元，52周低點爲0.32美元。